From AI-driven orchestration platforms to advanced data integration and oncology-specific analytics, clinical research tools are rapidly evolving to make trials faster, more accurate, and more patient ...

Paragonix Technologies, Inc., a pioneer in organ transplant technologies, organ offer, and surgical recovery services, today announced the presentation of new clinical research at the 2026 ...

Clinical dashboards are evolving from static data displays to powerful, AI-enhanced command centers for healthcare decision-making. By integrating patient-reported outcomes, real-time monitoring, and ...

As the first global CRO to embrace Medidata Plus, Worldwide unlocks the full AI layer of the Medidata Platform, harnessing the broad AI capabilities of Dot, Medidata’s virtual companion. This provides ...

Celerion’s services include data management, biostatistics, and clinical monitoring that supports pharmaceutical and ...

H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $74 billion of capital under management, is ...

Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying ...

Paradigm Health today announced SPIRE -- Scalable Platform for Integrated Research & Evidence -- a new model for post-approval and late-stage clinical studies designed to help sponsors generate ...

Discussion at the Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2026 recognises that artificial ...

(an Instem company), a leader in statistical computing infrastructure and clinical trial transparency, today announced the appointment of Christine Oliver as its President. Christine brings over two ...